Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Nuvectis Pharma, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 250 shares
@ $11.27, valued at
$2.8k
Bought 830 shares
@ $11.19, valued at
$9.3k
|
|
| 10/06/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 1,820 shares
@ $10.95, valued at
$19.9k
Bought 1,400 shares
@ $11.09, valued at
$15.5k
|
|
| 08/16/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 235 shares
@ $14.34, valued at
$3.4k
Bought 115 shares
@ $15.15, valued at
$1.7k
|
|
| 08/11/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 120 shares
@ $14.83, valued at
$1.8k
Bought 180 shares
@ $14.66, valued at
$2.6k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 1,556 shares
@ $13.98, valued at
$21.8k
|
|
| 07/27/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 10,000 shares
@ $13.97, valued at
$139.7k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 110 shares
@ $16.19, valued at
$1.8k
Bought 150 shares
@ $15.03, valued at
$2.3k
|
|
| 07/13/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 3,285 shares
@ $15.09, valued at
$49.6k
|
|
| 07/12/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 10,000 shares
@ $15.36, valued at
$153.6k
|
|
| 07/10/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 8,948 shares
@ $15.19, valued at
$135.9k
|
|
| 07/07/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 3,179 shares
@ $15.01, valued at
$47.7k
|
|
| 07/07/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 320 shares
@ $14.88, valued at
$4.8k
|
|
| 07/06/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 1,176 shares
@ $15.52, valued at
$18.3k
|
|
| 06/16/2023 |
4
| Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 400 shares
@ $17.54, valued at
$7k
Bought 31,724 shares
@ $17.71, valued at
$561.8k
|
|
| 06/08/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 230 shares
@ $17.41, valued at
$4k
Bought 120 shares
@ $17.53, valued at
$2.1k
|
|
| 06/01/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 330 shares
@ $17.28, valued at
$5.7k
|
|
| 05/26/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 200 shares
@ $17.49, valued at
$3.5k
|
|
| 05/18/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 320 shares
@ $17.025, valued at
$5.4k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 230 shares
@ $12.13, valued at
$2.8k
|
|
| 03/23/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 480 shares
@ $12.08, valued at
$5.8k
|
|
| 03/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 670 shares
@ $10.71, valued at
$7.2k
|
|
| 03/16/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Bought 1,680 shares
@ $10.85, valued at
$18.2k
Bought 480 shares
@ $10.91, valued at
$5.2k
|
|
| 01/13/2023 |
4
| Poradosu Enrique (Chief Science & Business Off) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Granted 115,000 shares
@ $0 |
|
| 01/13/2023 |
4
| BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Granted 210,000 shares
@ $0 |
|
|
|
|